Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupoint Application Plus Prunella vulgaris Formula Granules for Benign Thyroid Nodules
TCTR20260615002Phase 0Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of prunella vulgaris extract in benign thyroid nodule, sponsored by Chinese PLA General Hospital. Started Jan 2024; status: completed.
02
Drugs
prunella vulgaris extract
03
Conditions
benign thyroid nodule
Beyond the preview
Go deeper on TCTR20260615002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260615002.